AdvaMed

COVID-19 MedTech Resource Center

With our member companies on the frontlines of the fight against the COVID-19 pandemic, AdvaMed is working diligently to address the medtech industry’s needs and provide resources that support you and your businesses during this challenging time.

This website provides important information to companies about the federal response to COVID-19 — specifically those actions that directly impact the medtech industry — best practices, and other resources.

Latest Resources

Weekly AdvaMed COVID-19 Testing Registry Update: Total U.S. shipments of COVID-19 molecular diagnostic tests have reached 200 million

Learn More

FDA Commissioner Hahn at The Virtual MedTech Conference 2020: Safe COVID-19 Vaccines Will Be Approved by “Career Scientists,” Not Politicians

Learn More

First “ABC”—Flu A/B + COVID-19—Rapid Antigen Test Authorized by FDA

Learn More
Treasury Issues Supplement to PPP Interim Final Rule with Guidance for Self-Employed Individuals & Clarification of Business Eligibility
Treasury Updates FAQs for Paycheck Protection Program (PPP) with Information for Non-Bank Lenders to Participate
Treasury Announces Main Street Lending Program, Offering $600 Billion for Small and Mid-Sized Businesses

Upcoming Events

The Virtual MedTech Conference

On Demand Sessions Available: Sept. 8 – Oct. 23, 2020

Want to help?

AdvaMed is connecting companies with products to donate and/or manufacturing capacity with areas of most critical need.